Brief: Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
Dec 6 (Reuters) - Organovo Holdings Inc ONVO.O :
* ORGANOVO PROVIDES TIMING FOR RELEASE OF FXR314 PHASE 2
NASH
RESULTS
* ORGANOVO HOLDINGS INC - RELEASE FINAL AND COMPLETE DATA
FROM A
PHASE 2A TRIAL OF FXR314 IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
PATIENTS BY APRIL 2024
Source text for Eikon: ID:nGNX1SdJRQ
Further company coverage: ONVO.O
((Reuters.Briefs@thomsonreuters.com;))